腫瘍アブレーション治療の世界市場:高周波アブレーション、超音波アブレーション、冷凍アブレーション、マイクロ波アブレーション

◆英語タイトル:Global Tumor Ablation Market 2015-2019
◆商品コード:IRTNTR7589
◆発行会社(調査会社):Technavio
◆発行日:2015年12月30日
◆ページ数:70
◆レポート言語:英語
◆レポート形式:pdf
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥280,000見積依頼/購入/質問フォーム
Five UserUSD3,000 ⇒換算¥336,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥448,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、腫瘍アブレーション治療の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、腫瘍アブレーション治療の世界市場規模及び予測、技術別分析、地域別分析/市場規模、市場の成長要因、市場の課題、製品パイプライン分析、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。
【レポートの概要】

Tumor ablation is a minimally invasive, image-guided treatment procedure that is used to destroy cancer cells in the chest, lung, and liver. Recent advances in semiconductor technology and modifications to the design of medical laser systems such as MRI or ultrasound are responsible for this markets healthy growth rate of more than 15% during the forecast period.

Geographically, the EMEA region is expected to account for the highest market share during the forecast period. The growing prevalence of cancer in countries such as Denmark, Belgium, France, and Norway is responsible for this regions high market share of close to 37% by 2019.

Segmentation by ablation technology and analysis of the tumor ablation market
• Radiofrequency
• Ultrasound
• Cryotherapy
• Microwave

In this market research report, Technavio analysts estimate the radiofrequency segment to account for approximately 13% of the total market share by 2019. Radiofrequency is very specific for treating target tissues without causing significant damage to surrounding healthy cells. The high efficacy rate of this procedure is expected to bolster its growth during the forecast period.

Cancer-type segmentation of the tumor ablation market
• Liver
• Breast
• Prostate
• Gynecological
• Lung
• ENT

Technavios analyst has estimated the liver cancer segment to account for the highest market share during the forecast period. Liver cancer is more common in men than in women and is characterized by uncontrolled cell division in the liver. High incidence of primary liver cancer and bile duct cancer among the populace will result in this segments high market dominion during the forecast period.

This market offers ample growth opportunities to vendors during the forecast period and is characterized by the presence of numerous local and multinational vendors. While the international players are continually increasing their footprint in the market through product innovations, local vendors adopt collaborations to stay competitive in the market.

【レポートの目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Cancer statistics

PART 06: Pipeline analysis

PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 08: Market segmentation by ablation technology
• Radiofrequency ablation
• Ultrasound ablation
• Cryoablation
• Microwave ablation

PART 09: Market segmentation by cancer types
• Liver cancer
• Breast cancer
• Prostate cancer
• Gynecological cancer
• Lung cancer
• Ear, nose, and throat cancers

PART 10: Geographical segmentation
• Segmentation of global tumor ablation market by geography 2014-2019
• Tumor ablation market in Americas
• Tumor ablation market in EMEA
• Tumor ablation market in APAC

PART 11: Market drivers
• Increase in minimally invasive surgeries/procedures
• Rise in number of outpatient procedures
• Advances in technology
• Use of medical lasers for oncology procedures

PART 12: Impact of drivers

PART 13: Market challenges
• High cost of surgeries
• Risks associated with unskilled practitioners
• Risks associated with laser tumor ablation treatments
• Stringent regulatory approval process

PART 14: Impact of drivers and challenges

PART 15: Market trends
• Use of robotic navigation technologies
• Growing focus on emerging countries
• Focus on R&D
• Rise in accessibility of advanced laser treatments

PART 16: Vendor landscape
• Competitive scenario
• Key vendor analysis 2014
• Other prominent vendors

PART 17: Key vendor analysis
• AngioDynamics
• Boston Scientific
• Ethicon
• Medtronic

PART 18: Appendix
• List of abbreviations

PART 19: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Most prevalent cancer types in the world 2012
Exhibit 03: Countries with the highest cancer rate 2012
Exhibit 04: Pipeline analysis for tumor ablation devices
Exhibit 05: Global tumor ablation market segmentation
Exhibit 06: Global tumor ablation market 2014-2019 ($ millions)
Exhibit 07: Five forces analysis
Exhibit 08: Segmentation of global tumor ablation market by technology
Exhibit 09: Segmentation of global tumor ablation market by ablation technology 2014
Exhibit 10: Segmentation of global tumor ablation market by cancer types
Exhibit 11: Segmentation of global tumor ablation market by cancer type 2014
Exhibit 12: Segmentation of global tumor ablation market by geography 2014
Exhibit 13: Segmentation of global tumor ablation market by geography 2019
Exhibit 14: Segmentation of global tumor ablation market by geography 2014-2019
Exhibit 15: Image-guided minimally invasive procedures 2012 (million/year)
Exhibit 16: Tumor ablation market in Americas 2014-2019 ($ millions)
Exhibit 17: Prostate cancer incidence in top five European countries 2012
Exhibit 18: Tumor ablation market in EMEA 2014-2019 ($ millions)
Exhibit 19: Tumor ablation market in APAC 2014-2019 ($ millions)
Exhibit 20: Impact of drivers
Exhibit 21: Cost comparison of various tumor ablation procedures
Exhibit 22: Impact of drivers and challenges
Exhibit 23: Country wise healthcare spending 2010-2016 estimated ($ billions)
Exhibit 24: AngioDynamics: Key takeaways
Exhibit 25: Boston Scientific: Key takeaways
Exhibit 26: Ethicon: Key takeaways
Exhibit 27: Medtronic: Key takeaways
Exhibit 28: AngioDynamics: Business segmentation by revenue 2015
Exhibit 29: AngioDynamics: Business segmentation by revenue 2014 and 2015 ($ millions)
Exhibit 30: AngioDynamics: Segmentation of revenue by geography 2015
Exhibit 31: Boston Scientific: Business segmentation by revenue 2014
Exhibit 32: Boston Scientific: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 33: Ethicon : Product segmentation
Exhibit 34: Medtronic: Business segmentation 2015 by revenue
Exhibit 35: Medtronic: Business segmentation by revenue 2014 and 2015 ($ billions)



【掲載企業】

AngioDynamics, Boston Scientific, Ethicon, Medtronic, Alpinion Medical System, BSD Medical, Conmed, C2 Therapeutics, CSA Medical, C.R. Bard, Chongqing Haifu Medical Technology, Esaote, EDAP TMS, Galil Medical, InSightec, Misonix, Mermaid Medical, Monteris Medical, Neuwave Medical, Olympus, Perseon, Plasma Surgical, Profound Medical, Philips Healthcare, Smith & Nephews, Sonacare Medical, Shenzhen Huikang Medical Apparatus, Terumo Medical, Total Vein Systems, Theraclion, and Vivant Medical.

【レポートのキーワード】

腫瘍アブレーション治療、腫瘍切除、腫瘍切除術、腫瘍摘出、がん治療、高周波切除、高周波アブレーション、超音波アブレーション、冷凍アブレーション、マイクロ波アブレーション

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[腫瘍アブレーション治療の世界市場:高周波アブレーション、超音波アブレーション、冷凍アブレーション、マイクロ波アブレーション]販売に関する免責事項
★調査レポート[腫瘍アブレーション治療の世界市場:高周波アブレーション、超音波アブレーション、冷凍アブレーション、マイクロ波アブレーション]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆